Abstract: Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 (Cas9) technology has brought rapid progress in mammalian genome editing (adding, disrupting or changing the sequence of specific sites) by increasing the frequency of targeted events. However, gene knock-in of DNA cassettes by homologous recombination still remains difficult due to the construction of targeting vectors possessing large homology arms (from 2 up to 5 kb). Here, we demonstrate that in mouse embryonic stem cells the combination of CRISPR/Cas9 technology and targeting vectors with short homology arms (~ 0.3 kb) provides sufficient specificity for insertion of fluorescent reporter cassettes into endogenous genes with similar efficiency as those with large conventional vectors. Importantly, we emphasize the necessity of thorough quality control of recombinant clones by combination of the PCR method, Southern hybridization assay and sequencing to exclude undesired mutations. In conclusion, our approach facilitates programmed integration of Vol. 20. No. 5. 2015 CELL. MOL. BIOL. LETT. 774 exogenous DNA sequences at a target locus and thus could serve as a basis for more sophisticated genome engineering approaches, such as generation of reporters and conditional knock-out alleles.
INTRODUCTION
In 2007, Mario R. Capecchi, Martin J. Evans and Oliver Smithies were awarded the Nobel Prize in Medicine for introducing gene-specific modifications in embryonic stem cells, thereby generating knock-out and knock-in mouse models. Genetic changes are introduced by homologous recombination that occurs between an engineered exogenous DNA template and the genome of the mouse embryonic stem (mES) cells. Transgenic mES cells are then selected and used for chimera production by blastocyst injection or morula aggregation. Chimeras are backcrossed to achieve germline transmission and to generate transgenic mouse models. This method has been extensively used for decades to decipher the function of many mammalian genes in vivo. However, the use of this technique has been hampered due to several limitations: the low frequency of homologous recombination in mammalian cells, labor-intensive and timeconsuming selection and screening strategies, as well as construction of large targeting vectors with isogenic homology regions up to 10 kb to increase the targeting efficiency [1] . In recent years, discovery of new genome-editing technologies, such as zinc finger nucleases (ZFN), transcription activator-like effector nucleases (TALENs) and the clustered regularly interspaced short palindromic repeats (CRISPR) associated with CRISPR-associated 9 (Cas9) protein, has revolutionized generation of targeted mutations in many model organisms (see [2] for a review). All these technologies work on the same principle, i.e. sequenceguided DNA endonucleases induce DNA double-strand breaks (DSBs) that subsequently stimulate either non-homologous end joining (NHEJ) recombination and/or homology-directed repair (HDR) at targeted loci. The NHEJ recombination is an error-prone event forming small insertions or deletions (indels) and thus often results in frame-shift mutations. Because the HDR system requires a DNA template to repair a DSB, it is used to introduce a desired mutation or reporter gene into the genome. The template molecule is supplied in the form of either single-stranded oligonucleotides or doublestranded vectors. These vectors are typically designed to contain a selection marker that is flanked by genomic DNA fragments called 5´-and 3´-homology arms. Since it has been generally accepted that long homology arms are beneficial for increased gene-targeting efficiency [3] [4] [5] , targeting vectors have been routinely constructed with long homology arms up to 10 kb. Nowadays, with novel genome-editing technologies at hand, the homologous integration of large DNA fragments has greatly enhanced the ability to generate specific gene modifications. Nevertheless, ZFN and TALEN technologies still require a considerable cloning effort as multiple protein motifs need to be aligned in order to obtain site specificity. The CRISPR/Cas9 RNA-guided genome-editing tool is much simpler to implement. It only requires the Cas9 enzyme and an easily-edited guide RNA (gRNA) comprising a genome target sequence of 20 nucleotides (nt) followed by a 3-nt protospacer adjacent motif (PAM) nucleotide sequence: NGG. When these components are assembled in the nucleus at a specific locus guided by the 23 nt target sequence, Cas9 induces a DSB in the genome 3-4 nt upstream of the NGG site. In this study, we investigated the possibility to facilitate CRISPR/Cas9-based genome editing, particularly at the level of targeting vector design. We asked whether mES cells will repair a CRISPR/Cas9-induced DSB by homologous integration of a small or large DNA fragment with similar efficiencies. For this purpose, we prepared two types of targeting vectors that served as templates for homologous recombination: i) classical targeting vectors with long homology arms of 2 to 5 kb and ii) mini-targeting vectors carrying homology arms of only ~ 0.3 kb in length. Both types of targeting vectors carrying reporter cassettes were combined with a pair of gRNAs and pair of CRISPR nickases (Cas9D10A mutant version) that generate single strand breaks. A DSB and DNA insertion will occur only if two nicks are in close proximity (less than 200 bp), creating 5´ overhangs. The 5´ single-strand DNA overhangs invade the double-stranded molecule of exogenous targeting construct, thereby facilitating gene knock-in at a specific locus with minimal off-target activity [6] . We demonstrate with three different examples that combination of CRISPR/Cas9 nickases together with mini-targeting vectors leads to an overall insertion frequency comparable to conventional targeting vectors. Moreover, our approach using mini-targeting vectors (~ 0.3 kb homology arms) enables integration of even larger inserts (~ 2.3 kb). By Southern blot analysis we demonstrated that Cas9 nickases in combination with mini-targeting vectors led to insertion of foreign vector DNA also by non-homologous integrations, thus resulting in additional genomic alternations. This phenomenon was not observed when targeting vectors with long homology arms were used. Therefore we strongly recommend that Cas9-mediated integration of exogenous DNA with short homology arms always be accompanied by Southern blot analysis to eliminate clones with undesired genomic alterations at the targeting locus.
MATERIALS AND METHODS
Construction of Hnf4α-Venus, TagRFP-Tcf7L2 and Ngn3-Venus targeting vectors, and gRNA expressing vectors Knock-in targeting constructs for Hnf4α, Tcf7L2 and Ngn3 genes were designed as shown in Figure 1 . Primers used in this study to generate large targeting and mini-targeting vectors are listed in Suppl. Table 1 in Supplementary material at: 10.1515/cmble-2015-0047_sm.
Hnf4α-Venus knock-in cassette was designed to target Exon 10. For the minitargeting vector, the 5´ homology region (HR) and 3´ HR were PCR amplified using C57B16 BAC (RP23-156K9) as a template and using primers as follows: EP_1170 and EP_1171 primers for 5´ HR and EP_1172 and EP_1173 primers for 3´ HR. 5´ HR was subcloned via NotI and XbaI and 3´ HR was subcloned via HindIII and XhoI, into the pBluescript KS (pBKS), generating the pBKS-Hnf4α Ex10-HR. Using primers EP_1126 and EP_1127 on a Venus containing DNA template, a Venus-RGS-HisTag fragment (753 bp) was amplified and gel purified after XbaI and SpeI digestion and subcloned between 5´ and 3´ HRs, resulting in pBKS-Hnf4α Ex10-HR-Venus. The PGK promoter-driven neomycin resistance gene flanked by FRT sites (FRT-Neo-FRT) was released by BamHI and EcoRI digestion from the PL451-loxP [7] and cloned into these sites in the 3´ upstream sequence of Venus, resulting in pBKS-Hnf4α Ex10HR-Venus-Neo (Hnf4α-Venus mini-targeting vector). In order to generate a Hnf4α-Venus knock-in targeting vector with a large (more than 5 kbp) homology region, we prepared a retrieval plasmid containing a 5´ HR (EP_1178 and EP_1179) and a 3´ HR (EP_1180 and EP_1181) by cloning into HindIII/AscI and HindIII/SpeI sites, respectively, then into PL254 [8] . The resulting vector was linearized (5949 bp) with HindIII and NdeI, and electroporated into EL350 bacteria containing Hnf4α BAC, retrieving the wild type sequence between PCRs via bacterial homologous recombination (Hnf4α retrieval vector). Subsequently, the mini-targeting cassette (3165 bp) was released by digestion with NotI/XhoI and introduced into pL254-Hnf4α via bacterial homologous recombination in EL350 bacteria containing the retrieval vector. The final targeting construct (pL254-Hnf4α-Venus targeting vector; Fig. 1A ) was confirmed by sequencing. For the TagRFP-Tcf7L2 reporter, we cloned TagRFP into the Tcf7L2 start codon in order to create an N-terminally TagRFP-tagged Tcf7L2 fusion protein. The 5´ HR (EP_1210 and EP_1211) and 3´ HR (EP_1212 and EP_1213) of Exon1 were amplified by PCR using BAC (RP23-289C7) as a template and subcloned via NotI/BamHI and HindIII/SalI, respectively into pBKS, generating pBKSEx1Tcf7L2-HR. The TagRFP sequence without a stop codon was amplified from plasmid DNA (Evrogen) using EP_1214 and EP_1215 primers and cloned between 5´ and 3´ HR into EcoRI and HindIII sites, resulting in pBKS-Ex1 Tcf7L2-HR-TagRFP. PGK promoter-driven FRT-Neo-FRT was gel purified as a 1889 bp fragment after BamHI and EcoRI digestion of the PL451-loxP and ligated into the 5´ upstream sequence of TagRFP, resulting in pBKS-Ex1 Tcf7L2-HR-TagRFP-Neo. The retrieval vector for TagRFP-Tcf7L2 was prepared as follows: the retrieval 5´ HR (EP_1220 and EP_1221) and 3´ HR (EP_1222 and EP_1223) were amplified using Tcf7L2 BAC as a template. Products were subsequently cloned into AscI/SpeI and BamHI/SpeI sites of the PL254 vector [8] . The resulting vector was linearized with NdeI and SpeI (5895 bp) and electroporated into EL350 bacteria containing Tcf7L2 BAC, retrieving the wild type sequence between PCRs via bacterial homologous recombination (TcfL2 retrieval vector). Subsequently, the Tcf7L2 mini-targeting cassette was released by digestion with NotI and KpnI, and a 3256 bp fragment was introduced into pL254-Tcf7L2 via bacterial homologous recombination in EL350 bacteria containing the retrieval vector, resulting in the final targeting construct (pL254-TagRFP-Tcf7L2 targeting vector; Fig. 1B ), which was confirmed by sequencing. For cloning of the Ngn3-Venus knock-in cassette into Exon 2 of Ngn3, the 5´ (EP_ 1121 and EP_1122) and 3´ HR (EP_1123 and EP_ 1124) were amplified by PCR using BAC (RP23-121F10) as a template. PCR fragments were subcloned via NotI/XbaI and HindIII/XhoI, respectively, into pBKS, generating the pBKS-Ngn3 Ex2-HR. The Venus sequence was amplified from a Venuscontaining DNA template (EP_1126 and EP_1127) and cloned between the homology region of pBKS-Ex2 Ngn3-HR via ligation into XbaI and SpeI sites, resulting in pBKS-Ex2 Ngn3-HR-Venus. PGK promoter-driven FRT-Neo-FRT was cloned as the 1851 bp fragment after SmaI and HindIII digestion of the PL451-loxP vector [7] into the 3´ upstream sequence of Venus, resulting in pBKS-Ex2 Ngn3-HR-Venus-Neo (Fig. 1C) . Specific guide RNA sequences for target regions were selected according to http://crispr.mit.edu/ [9] . While the single strand breaks induced on opposite genomic strands were less then 100 bp apart, nicks on the targeting vectors were separated by about a 3 kb DNA sequence (by cassette-containing elements, e.g. pA, Neo, PGK) and therefore did not lead to DNA DSBs. To generate CRISPR expression vectors targeting specific genomic loci, a 20 bp sequence located 5´ of the PAM sequence was cloned into pBS-U6-chimericRNA. A pair of oligos was annealed by heating to 95°C and then cooled down at room temperature. A self-annealing oligo duplex generating BbsI overhangs was cloned into the BbsI-digested vector. Successful integration of CRISPRs into the pbs-U6-chimericRNA vector was confirmed by sequencing.
Cell culture and homologous recombination in mES cells
Mouse ES cells were cultured on a murine embryonic feeder (MEF) layer in Dulbecco´s Modified Eagle Medium (DMEM, Invitrogen) with high glucose (4500 mg/l) containing 15% fetal calf serum (FCS, PAN), 2 mM L-glutamine (from 200 mM stock; Invitrogen), 1 x MEM nonessential amino acids (from 100 x stock; Invitrogen), 0.1 mM β-mercaptoethanol (from 50 mM stock; Invitrogen) and 1500 U/ml LIF (leukemia inhibitory factor, Chemicon, 107 U/ml). Cells were split every two days using trypsin (0.05% Trypsin, 0.53 mM EDTA; Invitrogen) as described previously [10] . F1 hybrid (129Sv/C57Bl/6) mES cells (IDG3.2; [11] ) were electroporated using a Bio Rad Gene Pulser Xcell in 4 mm cuvettes at 250 V, 500 µF capacitance and ∞ ohms resistance. Prior electroporation minitargeting vectors were linearized with NotI and targeting vectors were linearized with AscI and were mixed with pbs-U6-chimericRNA and vector E-235 pCAGCas9v2D10A-bpA encoding nickase Cas9. For electroporation, 9 μg of Cas9n vector, 3 μg of each gRNA and 20 μg of targeting vector were used. Neo-resistant clones were selected at a final concentration of 300 μg/ml Geneticin (G418 sulfate; Invitrogen/Gibco). Targeting efficiency was assessed by Southern blot.
PCR genotyping
Correct integration of mini-targeting constructs was verified by PCR using genomic DNA of expanded mES cell clones as a template to amplify sequences around the gRNA target sites using the primers (Suppl. Table 1 ; primers for genotyping).
Southern blot analysis
Genomic DNA was separated on 0.7% (v/w) agarose gel after restriction digests with the appropriate enzymes, transferred to a positively charged nitrocellulose membrane (Roche) and hybridized with 32 P-labeled probes. The 3´ Southern probe for Hnf4α was PCR amplified (501 bp) using EP_1176 and EP_1177 primers from the described BAC. In the Southern hybridization assay of EcoRIdigested genomic DNA, the Hnf4α 3´ probe recognized a shift from 6881 bp (wt) to 6103 bp for the targeted allele. The Tcf7L2 5´ Southern probe (387 bp) was PCR amplified using EP_1216 and EP_1217 primers from the described BAC and in the Southern hybridization assay of HindIII-digested genomic DNA it recognized a shift from 9040 bp (wt) to 8219 bp for the targeted allele. The Ngn3 3´ Southern probe (603 bp) was PCR amplified using EP_1107 and EP_1108 primers from the described BAC and in the Southern hybridization assay of HindIII-digested genomic DNA it recognized a shift from 6937 (wt) to 4496 bp for the targeted allele.
On-target and off-target analysis
Mouse ES cells were digested overnight in lysis buffer (10 mM Tris-HCl pH 7.5, 10 mM EDTA, 10 mM NaCl, 0.5% (w/v) sarkosyl and 1 mg/ml proteinase K). Genomic DNA was extracted by NaCl/ethanol precipitation. For on-target analysis, the genomic sequences of several heterozygous clones for each targeting experiment were PCR amplified using primers flanking the target regions (Suppl. Table 1 ; primers for genotyping) and served for sequencing. Both wild-type and mutant (carrying either Venus or TagRFP) alleles were checked using primers as follows: primers used for sequencing of Hnf4α-Venus clones: wt allele -EP_1424, Venus allele -EP_1358; primers used for sequencing of TagRFP-Tcf7L2 clones: wt allele -EP_1431, TagRFP allele -EP_1430; primers used for sequencing of Ngn3-Venus clones: wt allele -EP_1373, Venus allele: EP_1429. Potential off-target sites for selected Hnf4α, Tcf7L2 and Ngn3 gRNAs were predicted by an online tool (available at http://crispr.mit.edu/guide/). Two putative off-target sites per each gRNA were PCR amplified from the genomic DNA of 3-5 individual gRNA-injected mES clones and analyzed by direct sequencing. The sequences were aligned with the wild-type sequence to detect if any indels were created.
RESULTS AND DISCUSSION
In the past, much effort has been devoted to generating targeting vectors carrying long homology arms of up to 10 kb in length using bacterial artificial chromosome (BAC) recombineering (see [7] for a review). Because manipulations of large DNA fragments are tedious and involve several cloning steps, target construct generation is cumbersome and time-consuming. With the implementation of the CRISPR/Cas9 system, targeting efficiency is theoretically boosted due to the Cas9-induced DSB at the targeted locus and cellular repair mechanisms that use a targeting vector as a template for repair. This encouraged us to test gene-targeting efficiencies using vectors with short homology arms (~ 0.3 kb) in combination with CRISPR/Cas9 technology. For this purpose, we generated both: i) mini-targeting constructs containing homology arms around 0.3 kb and ii) targeting constructs with homology arms of 5-7 kb in length using standard cloning techniques and bacterial recombination in order to generate Hnf4α-Venus and TagRFP-Tcf7L2 fusion constructs ( Fig. 1A and B) . The targeting strategy (see Materials and methods) was designed in such a way as to generate a C-terminal Hnf4α-Venus fusion protein or an N-terminal TagRFP-Tcf7L2 fusion protein. The TagRFP fluorescent reporter is an improved monomeric bright red fluorescent protein (RFP) [12] . For selection in mES cells, both targeting vectors contained a phospho-glycerate kinase (PGK) promoter-driven Neomycin (Neo) resistance gene cassette flanked by two flippase recognition target (FRT) and loxP sites, respectively. We decided to use the Cas9/double nicking approach with paired gRNAs that minimizes off-target cleavage [6] . The mini-targeting or targeting constructs for each locus were co-electroporated with a plasmid driving Cas9 nickase expression under the control of the CAG promoter and plasmids with two appropriate gRNAs driven by the human PolIII promoter U6 into F1 hybrid (129Sv/C57Bl/6) mES cells (IGD 3.2; [11] ). We picked and expanded 248 Neoresistant mES clones (149 with the mini-targeting and 99 with the targeting constructs) for the Hnf4α-Venus targeting and 177 Neo-resistant mES clones (58 with the mini-targeting and 119 with the targeting constructs) for the TagRFP-Tcf7L2 strategy (Table 1) . Homologous recombinants obtained by using mini-targeting vectors were confirmed by both PCR genotyping and Southern blotting (Fig. 1A and B and data not shown) . The primary screen was performed by PCR using a primer outside the arm of homology in combination with a primer specific for the cassette to amplify the mutant allele (PCR A; Fig. 1A and B) . Using this PCR strategy specific for the knock-in allele, 26% of Hnf4α-Venus clones and 50% of TagRFP-Tcf7L2 clones were identified as recombinants at the target locus. Strikingly, Southern blotting revealed that out of 149 clones, 7 were homozygous and 34 heterozygous Hnf4α-Venus recombinants (27.5%), whereas for the TagRFP-Tcf7L2 construct, out of 58 clones, 11 were heterozygous (18.9%) ( Table 1) . However, Southern hybridization revealed that some clones showed multiple bands ( Fig. 2 ; an example for Hnf4α clones is shown). This was most likely due to insertion of the targeting vector via a nonhomologous mechanism at the targeting locus that resulted in genomic alterations, such as concatemer formation, duplications or inversions. Whether linearization of targeting vectors could have caused those alternations was not further analyzed. In Table 1 and Figure 2 these clones represent the category called "other". These clones could only be detected by Southern blot analysis and were only observed with the mini-targeting vectors, but not with the conventional targeting vectors, illustrating that larger homology arms increase the fidelity of homologous recombination. The number of recombinants identified by PCR and Southern blot analysis correlated better for mES clones obtained with the Hnf4α-Venus mini-targeting vector, though not perfectly.
This difference was likely caused by inability to amplify the mutant allele by PCR in several clones due to the presence of indels. Therefore, we wondered if we can distinguish wild type clones and recombinants with the cassette integrated in a homozygous and heterozygous manner by multiple PCR with three primers recognizing either the 5´ region of the transgene or the wild-type sequence (PCR B; Fig. 1A ). This PCR strategy based on the different size of transgenic (481 bp) and non-transgenic (400 bp) products revealed that out of 22 analyzed clones (previously identified by a PCR specific for the knock-in allele) only 4 (18%) were identified as heterozygous mutants and 18 (82%) clones were identified as homozygous mutants (data not shown). This was in contrast to our Southern blot analysis where only 12.3% of homozygous clones (7 out of 57) were identified. To clarify this discrepancy we sequenced all 22 clones that were identified by PCR as homozygous or heterozygous targeted. Fig. 2 . Southern blot analysis of the mES cell clones electroporated by mini-targeting Hnf4α-Venus construct. Genomic DNA was digested with EcoRI and probed with the Hnf4α 3´ radiolabeled probe (see Material and methods). The probe was used to recognize the wildtype allele (wt; 6881 bp) and targeted allele (Neo; 6103 bp). mES cell clones were categorized into four groups: wild type (1), clones with a homozygously (2) or heterozygously (3) integrated cassette, and clones with the cassette integrated in an undesired manner (4), in the text also referred to as "others". A representative part of two membranes of the same experiment is shown to demonstrate all types of clones.
This revealed that indels caused by Cas9-mediated DSBs precluded binding of primers to the wt sequence in those clones that were identified as heterozygous by Southern blot but were homozygous by PCR (Fig. 3A) . Thus, the design of a PCR primer overlying the gRNA target sequence is an efficient way to screen for indels on the wild-type allele. We further tested this hypothesis and designed a new primer that is derived from a site more downstream from the gRNA #24 binding site (Fig. 3A) . Using this strategy (PCR C; Fig. 1A ) we were able to detect the presence of the wild-type allele in Southern blot-identified heterozygous clones (data not shown). On the other hand, small deletions were not detected by Southern hybridization assay, but were found by direct sequencing. This emphasizes the necessity to verify the gene targeting by Southern blot, sequencing and PCR analysis. The targeting efficiencies using (Table 1) . Remarkably, homozygous clones were only obtained with the mini-targeting constructs, likely due to the higher transfection efficiency of the smaller vectors. Based on these two targeting strategies, it appeared that vectors with short homology arms combined with two guide RNAs provide sufficient specificity for gene targeting in mES cells. To seek further evidence for this idea, we used the same knock-in strategy with mini-targeting vectors for a third target locus. We designed two gRNAs targeting the translational stop codon of Exon 2 of the Ngn3 locus to generate a C-terminal Ngn3-Venus fusion reporter (Fig. 1C) . The strategy yielded 28.8% Ngn3-Venus mES cell clones based on Southern blot analysis ( Table 1 ), confirming that our targeting strategy reveals a high number of recombined clones at independent loci. To detect NHEJ-induced indel mutations, we analyzed the wild-type allele of selected heterozygous clones for each targeting experiment by direct sequencing. Eleven out of 22 Hnf4α-Venus clones showed small deletions (Fig. 3A) , and in four clones large deletions ranging from 104 to 211 bp at the target site were detected (not shown). In the case of TagRFP-Tcf7L2, in two out of six clones indels were observed (Fig. 3B) and two out of eleven Ngn3-Venus clones showed small indels (Fig. 3C) . Another clone exhibited a deletion of 271 bp at the target site (data not shown). The ends of the DSBs in different deletion alleles vary in length because they are repaired via the NHEJ pathway. The sequence of the reporter (Venus or TagRFP) allele of the selected clones was also verified and no mutations were detected (data not shown). Finally, we assessed the specificity of all gRNAs used in this work. Two putative off-target (OT) sites per gRNA were computationally predicted (see Materials and methods), PCR amplified and sequenced using genomic DNA of three to five individual clones (Table 2) . No indels were detected at any OT site. Our results are in line with previous findings of the Zhang laboratory and suggest that the Cas9 nickases combined with two gRNAs minimizes off-target effects [6] . In summary, our targeting strategy using mini-targeting vectors possessing ~ 0.3 kb homology arms combined with CRISPR/Cas9 technology at three different loci proved feasible and efficient. Through improvement, the strategy allowed the integration of reporter transgenes also in a homozygous manner that was not achieved with conventional targeting vectors. Additionally, generating heterozygous reporter alleles in which the other allele is either wild type or carrying an indel frameshift mutation will be extremely useful for cell lineage and gene functional analysis. Now several studies on the successful use of the CRISPR/Cas9 system and targeting vectors with very short homology arms have been published in different organisms, e.g. in zebrafish [13] and in nematode [14] . However, to our knowledge, only one study has explored the influence of the length of the homology arms on Cas9-mediated integration of donor DNA into the genome of higher eukaryotes. The study of Li and his co-workers [15] reached similar conclusions, i.e. it was recommended to use homology arms of 0.2-0.4 kb for large DNA insertions and homology arms of 0.05 kb for insertion of small DNA fragments. However, in contrast to our study, the authors investigated only the recombination borders at the targeting site by PCR and sequencing. Based on our results, it is evident that targeting vectors with small homology arms tend to integrate via NHEJ mechanisms causing various rearrangements that can only be detected by Southern blot analysis, and thus PCR genotyping alone is not sufficient. We further demonstrated that a threeprimer PCR set-up can provide valuable information about homo-or heterozygosity of the targeted clones. To detect indels on the wild-type allele, further validation by sequencing is necessary but can also be detected by PCR using primers spanning the gRNA target site. Targeting three different loci with similar high efficiencies illustrates the great advantage of combining minitargeting vectors with the CRISPR/Cas9 gene-editing approach. Our study will help to design and validate targeting strategies for sophisticated genome engineering, such as the insertion of an epitope, a fluorescent reporter gene or generation of a conditional knock-out allele.
